Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

NGR-human tumour necrosis factor

EU orphan designation number: EU/3/08/549   
Active ingredient: NGR-human tumour necrosis factor
Indication: Treatment of malignant mesothelioma
Sponsor: MolMed S.p.A.
Via Olgettina 58, I-20132 Milano, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/06/2008 Orphan designation EMEA/OD/003/08 (2008)2532 of 03/06/2008